drugset / Trial / NCT00159523

Impact in Off-spring of Mothers After Perinatal Daily Intake of a Probiotic

NCT00159523 ↗

RandomizedParallel-groupDouble-blindPrevention

Summary

A probiotic (Lactobacillus rhamnosus GG) supplement to pregnant women the last four weeks of pregnancy and three months after birth is expected to give a 40% reduction in risk of atopic sensitisation and allergic disease at two years of age, compared to placebo.

Timeline

Start
2003-12
Primary completion
2007-09
Completion
2007-09

Outcome

Met primary endpoint

paper CONCLUSIONS:   Probiotics given to nonselected mothers reduced the cumulative incidence of AD PMID 20545688 ↗

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Bifidobacterium animalis subsp. lactis BB-12 Other / unclassified — Oral
Subject Lactobacillus rhamnosus GG Other / unclassified — Oral
Subject Probiotic Other / unclassified — Oral